Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FREEDOM-M: Oral Treprostinil Monotherapy in PAH
NCT00325403Phase 3Completed
- Sponsor
- United Therapeutics Corporation
- Start
- Oct 2006
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 13
01
Overview
A Phase 3 trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by United Therapeutics Corporation. Started Oct 2006; status: completed.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00325403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325403.